全球性疾病需要全球性的解决方案:阿尔茨海默氏症
Emma Twiss1, Carley McPherson2, Donald F Weaver1,3
1Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada.
Neurology international
|June 25, 2025
概括
阿尔茨海默病 (AD) 是一个日益严重的全球危机. 本综述概述了在研究,诊断,治疗,预防和教育方面开展国际合作的五项行动,以打击AD.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 老年学是指老年学的学科.
背景情况:
- 由于人口老龄化,阿尔茨海默病 (AD) 的发病率和流行率在全球范围内正在增加.
- 预测估计到2050年,超过1.5亿人将患有AD,没有治愈疗法.
- 全球气温上升和空气污染等环境因素与痴呆风险有关,需要紧急的国际行动.
研究的目的:
- 为了应对阿尔茨海默氏症 (AD) 全球卫生紧急情况.
- 提出五个关键的行动呼吁,为协调的国际反应提供帮助.
- 概述研究,诊断,治疗,预防和护理的策略.
主要方法:
- 本综述综合了当前的知识,并提出了一个战略框架.
- 它确定了全球合作和干预的关键领域.
- 专注于研究,诊断,治疗,降低风险和护理的可行的步骤.
主要成果:
- 提出了五个行动呼吁: 1. 通过数据共享和LMIC访问,国际化AD研究. 2. 2. 2. 这是一个很棒的节目. 开发可访问的,负担得起的,非侵入性诊断. 3. 3. 3. 3. 这是一件很棒的事情. 优先考虑全球分销的负担得起的治疗药物. 4. 4. 4. 4. 这是一个很棒的节目. 实施SHIELD战略 (睡眠,预防头部伤害,运动,学习,饮食) 以减少痴呆风险. 5. 5. 5. 这是一个很大的问题. 通过对公众和护理人员的教育,消除耻辱.
结论:
- 需要一个前所未有的全球联盟来解决不断升级的AD危机.
- 在研究,诊断,治疗,预防和教育方面的协调努力至关重要.
- 如果不采取行动,AD可能会成为这个时代的决定性危机.
相关概念视频
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:26Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
01:30Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
01:15Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722